Naproxen and Parnaparin: Interaction Details
- Naproxen
- AleveAnaproxAnaprox DS +13 more
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Naproxen and Parnaparin interaction:
Naproxen
- Aleve
- Anaprox
- Anaprox DS
- EC-Naprosyn
- Flanax
- Naprelan
- Naprosyn
- Wal-Proxen
- Aleve Headache Pain
- Flanax Pain Reliever/Fever reducer
- Medique Mediproxen
- Aleve Back and Muscle Pain
- Belmora Flanax
- Bayer Aleve
- Aleve Easy Open Arthritis Cap
- Aleve Gelcaps
Parnaparin
We don't have a drug information page for Parnaparin yet. Have a question about Parnaparin? Ask a pharmacist, free →
What Happens When You Take Naproxen With Parnaparin
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Giving together with low-molecular-weight heparins (LMWH) or heparinoids can raise the likelihood of serious bleeding, among them epidural or spinal hematomas in patients undergoing neuraxial anesthesia or spinal puncture. When feasible, the should be stopped before LMWH therapy begins.2 Should an LMWH and an NSAID both be necessary, patients need to be watched closely for signs and symptoms of bleeding, and extreme caution is advised.1
The Naproxen and Parnaparin Interaction, Explained
Naproxen (Aleve) is a pain reliever that can make your , the cells that help blood clot, work less well. Parnaparin is a that slows clotting in a different way. Taking them together can raise your chance of serious bleeding, such as bleeding in the stomach or, rarely, around the spine if you have a spinal procedure or epidural.
Please don't stop or change either medicine on your own. Tell your pharmacist or doctor that you take both. They can decide whether naproxen should be avoided or whether you need closer monitoring. Call right away if you notice black stools, unusual bruising, or bleeding that won't stop.
Mechanism: Naproxen inhibits COX-1 (reversible), reducing thromboxane A2 and aggregation, and also causes mucosal injury. Parnaparin, an LMWH, potentiates antithrombin and inhibits factor Xa and IIa. The result is impairment of hemostasis. This is not a interaction, and neither drug is a .
- Effect: increased risk of major bleeding, including epidural or spinal hematoma with neuraxial anesthesia or spinal puncture.
- Severity/evidence: major; probable. Onset unspecified.
- Management: discontinue the before starting the LMWH when possible. If is required, use extreme caution and monitor closely for signs and symptoms of bleeding (GI, neurologic changes after neuraxial procedures).
See the 6 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Naproxen and Parnaparin Interact
The likely mechanism
Decreased function; decreased coagulation
How to Manage the Naproxen and Parnaparin Interaction
The usual approach is to stop the before the is started, when possible. That decision belongs to your prescriber. If you truly need both, your care team will use extra caution and watch you closely for bleeding.
- Keep taking your medicines exactly as prescribed until your team advises otherwise.
- Tell your pharmacist and doctor about all pain relievers you use, including over-the-counter Aleve.
- Tell your anesthesia or procedure team that you take both before any epidural or spinal procedure.
- Report unusual bruising, black or bloody stools, or new back pain, numbness, or weakness right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Naproxen or Parnaparin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
4 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Epidural hematoma in an ambulatory surgical patient
A 60-year-old woman who was taking aspirin, naproxen, nifedipine, captopril, cimetidine, and potassium supplements was scheduled for an ambulatory arthroscopic lateral meniscectomy. She was given 30 mg of a low-molecular-weight heparin 90 minutes before epidural anesthesia was started.
The surgery was uneventful, and she went home with full motor and sensory function. About 2 hours later she developed severe lumbar back pain, and she came back to the hospital 90 minutes after that.
By then she had lost motor function in both lower extremities. Computerized tomography showed an epidural hematoma, which was removed in emergency surgery.
By the second postoperative day she had recovered full motor and sensory function. Aspirin, , and low-molecular-weight heparin are each regarded as safe when given alone before a neuraxial block, but the combination of all 3 agents was thought to be responsible for the epidural hematoma in this patient.3
-
Report 2 · Study title
Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?
Sixty patients having total hip replacement were randomized into 2 groups to assess whether of enoxaparin and ketorolac could cause excessive postoperative bleeding. Any earlier therapy had been stopped 4 weeks before surgery.
All patients were given enoxaparin 40 mg subcutaneously 12 hours before surgery and then once daily for 10 days. Twenty-six patients also received ketorolac 30 mg intramuscularly at of anesthesia, followed by 30 mg once daily for 4 days.
The remaining 34 patients received enoxaparin along with and acetaminophen analgesia. The groups did not differ significantly in intraoperative blood loss, postoperative drainage, transfusion requirements, wound oozing, bruising, or leg swelling.
In addition, no patient had a clinically detectable . The authors proposed that the risk of increased bleeding from combined use of a low-molecular-weight heparin and an NSAID is low when the NSAID dose is modest.4
-
Report 3 · Study title
Increased blood loss after preoperative NSAID
In a retrospective study of patients who received enoxaparin during hip replacement surgery, perioperative blood loss and the use of blood transfusions were significantly higher in patients who had used before surgery than in those who had not. The two groups did not differ in postoperative blood loss.5
-
Report 4 · Study title
Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis
A double-blind, placebo-controlled, randomized, crossover study evaluated the hemostatic interaction between ketorolac and dalteparin in 24 healthy male volunteers aged 18 to 55 years, each of whom received all 4 combinations of ketorolac/placebo and dalteparin/placebo. Ketorolac inhibited aggregation in whole blood and in platelet-rich plasma, and this prolonged the skin bleeding time.
After dalteparin administration, antifactor Xa levels increased significantly and the activated partial thromboplastin time was significantly prolonged, although values stayed within the range of the normal population. Ketorolac and dalteparin interacted to prolong bleeding time, whereas dalteparin alone had no effect on it. complications may be possible perioperatively when dalteparin and ketorolac are given together.6
Naproxen and Parnaparin: Common Questions
How serious is the Naproxen and Parnaparin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Naproxen and Parnaparin interaction managed?
The usual approach is to stop the before the is started, when possible. That decision belongs to your prescriber. If you truly need both, your care team will use extra caution and watch you closely for bleeding. Keep taking your medicines exactly as prescribed until your team advises otherwise. Tell your pharmacist and doctor about all pain relievers you use, including over-the… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Naproxen and Parnaparin Interaction
Ask in your own words about taking Naproxen and Parnaparin together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (6)
- Product Information: SPRIX(TM) nasal spray, ketorolac tromethamine nasal spray. Roxro Pharma, Inc, Menlo Park, CA, 2009. DailyMed
- Product Information: Lovenox(R) subcutaneous injection, intravenous injection, enoxaparin sodium subcutaneous injection, intravenous injection. Sanofi-Aventis U.S. LLC (per FDA), Bridgewater, NJ, 2013. DailyMed
- Porterfield WR & Wu CL: Epidural hematoma in an ambulatory surgical patient. J Clin Anesth 1997; 9:74-76. PubMed
- Weale AE, Warwick DJ, Durant N, et al: Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?. Ann R Coll Surg Engl 1995; 77:35-37.
- Fauno P, Petersen KD, & Husted SE: Increased blood loss after preoperative NSAID. Acta Orthop Scand 1993; 64:522-524.
- Greer IA, Gibson JL, Young A, et al: Effect of ketorolac and low-molecular-weight heparin individually and in combination on haemostasis. Blood Coagul Fibrinolysis 1999; 10:367-373. PubMed
Other Serious Interactions of Naproxen and Parnaparin
Also serious with Naproxen
- KetorolacContraindicated
- Ketorolac InjectionContraindicated
- Ketorolac Nasal SprayContraindicated
- Ketorolac OphthalmicContraindicated
Also serious with Parnaparin
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Naproxen
- Activated CharcoalMajor
- WineMajor
- AsarabaccaMajor
- BeerMajor
- PiracetamMajor
- Siberian CockleburMajor
- Vitamin EModerate
- SeleniumModerate
- + 310 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.